Oxidized phospholipids induce anergy in human peripheral blood T cells

Eur J Immunol. 2008 Mar;38(3):778-87. doi: 10.1002/eji.200737619.

Abstract

Lipids are key regulators of immune responses. In this study we investigated the direct impact of oxidized phospholipids (ox-PL) on T cell activation and function. We could demonstrate that ox-PL strongly inhibit proliferation of purified human T cells induced with anti-CD3/CD28 or anti-CD3/CD63 mAb, whereas proliferation of naive T cells from human cord blood was not affected by ox-PL. Unoxidized phospholipids showed no such effect. Inhibition of T cell proliferation by ox-PL was not due to cell death. Moreover, T cell proliferation triggered by PMA/ionomycin activation was not diminished by ox-PL. T cells activated in the presence of ox-PL produced and released low amounts of IFN-gamma and IL-2, whereas IL-4 was only slightly diminished. Ox-PL prevented the expression of de novo synthesized activation markers (CD25, MHC class II) but not expression of CD63 or CD69. We further observed that T cells stimulated in the presence of ox-PL are poorly cytotoxic T cells. Most importantly, T cells activated in the presence of ox-PL failed to proliferate in response to restimulation. This hypo-proliferative state was accompanied with an up-regulation of early growth response gene 3 and Casitas B-lineage lymphoma protein B. Taken together, our results demonstrate that ox-PL are potent and specific regulators of T cell activation and function.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibodies, Monoclonal / immunology
  • Antibodies, Monoclonal / pharmacology
  • Antigens, Differentiation, T-Lymphocyte / metabolism
  • CD3 Complex / immunology
  • Cell Differentiation / drug effects
  • Cell Differentiation / immunology
  • Cell Proliferation / drug effects*
  • Cells, Cultured
  • Clonal Anergy / drug effects*
  • Cytokines / metabolism
  • Cytotoxicity, Immunologic / drug effects
  • Early Growth Response Protein 3 / genetics
  • Gene Expression / drug effects
  • Histocompatibility Antigens Class II / metabolism
  • Humans
  • Lymphocyte Activation / drug effects
  • Oxidation-Reduction
  • Phosphatidylglycerols / chemistry
  • Phosphatidylglycerols / pharmacology
  • Phosphatidylserines / chemistry
  • Phosphatidylserines / pharmacology
  • Phospholipid Ethers / chemistry
  • Phospholipid Ethers / pharmacology
  • Phospholipids / chemistry
  • Phospholipids / pharmacology*
  • Proto-Oncogene Proteins c-cbl / genetics
  • T-Lymphocytes / cytology
  • T-Lymphocytes / drug effects*
  • T-Lymphocytes / metabolism
  • T-Lymphocytes, Cytotoxic / cytology
  • T-Lymphocytes, Cytotoxic / drug effects
  • T-Lymphocytes, Cytotoxic / metabolism

Substances

  • 1-palmitoyl-2-(5-oxovaleroyl)-sn-glycero-3-phosphorylcholine
  • 1-palmitoyl-2-glutaroyl-sn-glycero-3-phosphorylcholine
  • Antibodies, Monoclonal
  • Antigens, Differentiation, T-Lymphocyte
  • CD3 Complex
  • Cytokines
  • EGR3 protein, human
  • Histocompatibility Antigens Class II
  • Phosphatidylglycerols
  • Phosphatidylserines
  • Phospholipid Ethers
  • Phospholipids
  • Early Growth Response Protein 3
  • Proto-Oncogene Proteins c-cbl